Still, increased production of ISGs and IFN-mediated inflammatory responses after SARS-CoV-2 infection of monocyte-derived cells were previously described (76, 77) and the relevance of monocytes/macrophages with respect to the clinical outcome of COVID-19 is widely accepted (78, 79). This evidence concerns the gene IFNA1 and COVID-19.